I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Charles Steenbergen, Jr, M.D., Ph.D.
Professor of Pathology
Expertise: Cardiovascular Pathology, Pathology, Transplant Pathology
Research Interests: Cardiovascular Diseases, particularly Ischemia-Reperfusion Injury
The Johns Hopkins Hospital (Main Entrance)
1800 Orleans St. Sheikh Zayed Tower Baltimore, MD 21287
Johns Hopkins Outpatient Center
601 N. Caroline St. Baltimore, MD 21287
Johns Hopkins Bayview Medical Center
4940 Eastern Avenue Baltimore, MD 21224
Dr. Charles Steenbergen is a professor of pathology at the Johns Hopkins University School of Medicine. He specializes in cardiovascular and transplant pathology, with particular focus on the mechanisms of ischemic heart disease.
Dr. Steenbergen received an M.D. and a Ph.D. from the University of Pennsylvania. He completed a residency in anatomic pathology and a fellowship in pathology at Duke University.
He is certified in anatomic pathology by the American Board of Pathology.
- Professor of Pathology
Centers & Institutes
- MD, University of Pennsylvania School of Medicine (1978)
- Duke University School of Medicine / Anatomic Pathology (1984)
- American Board of Pathology / Anatomic Pathology (1985)
Research & Publications
Dr. Steenbergen’s research focuses on mechanisms of ischemic heart disease, and in particular, endogenous mechanisms that can be activated to protect the heart during a subsequent episode of ischemia and reperfusion.
He is interested in identifying signal transduction pathways that are involved in cardioprotection, and understanding how these signaling pathways confer their protective effect.
His lab studies the mechanisms of injury involving ionic dysequilibrium, and has used magnetic resonance spectroscopic techniques to monitor ion concentrations in intact hearts during ischemia and reperfusion. Since infarct size is a major determinant of clinical outcome in patients with ischemic heart disease, the lab hopes that better understanding of these protective mechanisms will lead to the development of better therapies for patients with coronary artery disease and patients undergoing heart surgery.
Murphy, E. and Steenbergen, C.: Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008; 88: 581-609.
Das, S., Ferlito, M., Kent, O.A., Fox-Talbot, K., Wang, R., Liu, D., Raghavachari, N., Yang, Y., Wheelan, S.J., Murphy, E., Steenbergen, C. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ. Res. 2012; 110: 1596-1603.
Yano, T., Ferlito, M., Aponte, A., Kuno, A., Miura, T., Murphy, E., Steenbergen, C. Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling. Circ. Res. 2014; 114: 1268-1280.
Kohr, M.J., Murphy, E., Steenbergen, C. Glyceraldehyde-3-phosphate dehydrogenase acts as a mitochondrial trans-S-nitrosylase in the heart. PLoS One. 2014; 9: e111448.
Sun, J., Nguyen, T., Aponte, A.M., Menazza, S., Kohr, M.J., Roth, D. M. Patel, H.H., Murphy, E., Steenbergen, C. Ischemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria. Cardiovasc. Res. 2015; 106: 227-236.